Compare
Scienture Holdings, Inc. vs America Great Health vs Quantum Cyber N.V. vs Silence Therapeutics plc
| Latest fiscal year | Scienture Holdings, Inc. SCNX | America Great Health AAGH | Quantum Cyber N.V. QUCY | Silence Therapeutics plc SLN |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-06-30 | 2025-12-31 | 2025-12-31 |
| Revenue | $431.6K | $391.7K | $537.1K | $559.0K |
| Revenue growth (YoY) | +215.9% | +32.9% | -39.9% | -98.7% |
| Gross margin | 76.8% | 86.6% | 72.6% | 61.5% |
| Operating margin | n/m | -97.8% | n/m | n/m |
| Net margin | n/m | -183.6% | n/m | n/m |
| Net income | -$41.51M | -$719.1K | -$16.21M | -$88.61M |
| EPS (Diluted) | -$2.70 | $0.00 | -$2.70 | -$0.63 |
| Operating cash flow | -$13.38M | -$332.9K | -$10.98M | -$62.27M |
| Free cash flow | n/a | n/a | -$10.98M | -$62.33M |
| Cash & equivalents | $6.66M | n/a | n/a | $11.28M |
| Total assets | $84.18M | $301.8K | $5.33M | $131.44M |
| Total liabilities | $14.06M | $6.05M | $4.69M | $69.14M |
| Shareholders' equity | $70.12M | -$5.66M | $641.6K | $62.30M |
| Return on year-end equity | -59.2% | n/a | n/m | -142.2% |
| Shares outstanding | 40.63M | 21.15B | 9.78M | 141.70M |
Revenue, most recent five fiscal years
| Fiscal year | Scienture Holdings, Inc. | America Great Health | Quantum Cyber N.V. | Silence Therapeutics plc |
|---|---|---|---|---|
| Latest | $431.6K Ended 2025-12-31 | $391.7K Ended 2025-06-30 | $537.1K Ended 2025-12-31 | $559.0K Ended 2025-12-31 |
| 1 year earlier | $136.6K Ended 2024-12-31 | $294.7K Ended 2024-06-30 | $894.0K Ended 2024-12-31 | $43.26M Ended 2024-12-31 |
| 2 years earlier | $1.36M Ended 2023-12-31 | $204.3K Ended 2023-06-30 | n/a | $31.64M Ended 2023-12-31 |
| 3 years earlier | $10.25M Ended 2022-12-31 | $104.6K Ended 2022-06-30 | n/a | $21.66M Ended 2022-12-31 |
| 4 years earlier | $9.89M Ended 2021-12-31 | $195.7K Ended 2021-06-30 | n/a | n/a |